246 related articles for article (PubMed ID: 18330978)
1. An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Cherkasov A; Ban F; Santos-Filho O; Thorsteinson N; Fallahi M; Hammond GL
J Med Chem; 2008 Apr; 51(7):2047-56. PubMed ID: 18330978
[TBL] [Abstract][Full Text] [Related]
2. Structural analyses of sex hormone-binding globulin reveal novel ligands and function.
Avvakumov GV; Cherkasov A; Muller YA; Hammond GL
Mol Cell Endocrinol; 2010 Mar; 316(1):13-23. PubMed ID: 19748550
[TBL] [Abstract][Full Text] [Related]
3. In silico identification of anthropogenic chemicals as ligands of zebrafish sex hormone binding globulin.
Thorsteinson N; Ban F; Santos-Filho O; Tabaei SM; Miguel-Queralt S; Underhill C; Cherkasov A; Hammond GL
Toxicol Appl Pharmacol; 2009 Jan; 234(1):47-57. PubMed ID: 18725242
[TBL] [Abstract][Full Text] [Related]
4. 'Inductive' charges on atoms in proteins: comparative docking with the extended steroid benchmark set and discovery of a novel SHBG ligand.
Cherkasov A; Shi Z; Li Y; Jones SJ; Fallahi M; Hammond GL
J Chem Inf Model; 2005; 45(6):1842-53. PubMed ID: 16309292
[TBL] [Abstract][Full Text] [Related]
5. Successful in silico discovery of novel nonsteroidal ligands for human sex hormone binding globulin.
Cherkasov A; Shi Z; Fallahi M; Hammond GL
J Med Chem; 2005 May; 48(9):3203-13. PubMed ID: 15857126
[TBL] [Abstract][Full Text] [Related]
6. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
7. Multi-target QSAR and docking study of steroids binding to corticosteroid-binding globulin and sex hormone-binding globulin.
Nikolic K; Filipic S; Agbaba D
Curr Comput Aided Drug Des; 2012 Dec; 8(4):296-308. PubMed ID: 22242800
[TBL] [Abstract][Full Text] [Related]
8. Atom-based 3D-chiral quadratic indices. Part 2: prediction of the corticosteroid-binding globulinbinding affinity of the 31 benchmark steroids data set.
Castillo-Garit JA; Marrero-Ponce Y; Torrens F
Bioorg Med Chem; 2006 Apr; 14(7):2398-408. PubMed ID: 16325409
[TBL] [Abstract][Full Text] [Related]
9. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
10. Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions.
Abu Hammad AM; Afifi FU; Taha MO
J Mol Graph Model; 2007 Sep; 26(2):443-56. PubMed ID: 17360207
[TBL] [Abstract][Full Text] [Related]
11. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
Holder S; Lilly M; Brown ML
Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors.
Sheng C; Zhu J; Zhang W; Zhang M; Ji H; Song Y; Xu H; Yao J; Miao Z; Zhou Y; Zhu J; Lü J
Eur J Med Chem; 2007 Apr; 42(4):477-86. PubMed ID: 17349719
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors.
Durdagi S; Mavromoustakos T; Papadopoulos MG
Bioorg Med Chem Lett; 2008 Dec; 18(23):6283-9. PubMed ID: 18951793
[TBL] [Abstract][Full Text] [Related]
17. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
Salum Lde B; Polikarpov I; Andricopulo AD
J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
[TBL] [Abstract][Full Text] [Related]
18. Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases.
Politi A; Durdagi S; Moutevelis-Minakakis P; Kokotos G; Papadopoulos MG; Mavromoustakos T
Eur J Med Chem; 2009 Sep; 44(9):3703-11. PubMed ID: 19410337
[TBL] [Abstract][Full Text] [Related]
19. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
20. Using molecular docking, 3D-QSAR, and cluster analysis for screening structurally diverse data sets of pharmacological interest.
Santos-Filho OA; Cherkasov A
J Chem Inf Model; 2008 Oct; 48(10):2054-65. PubMed ID: 18816024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
